106542 Federal Register / Vol. 89, No. 249 / Monday, December 30, 2024 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

BRAIN Initiative: Engineering and 

Optimization of Molecular Technologies for 

Functional Dissection of Neural Circuits 

(UM1). 

Date: February 4, 2025. 

Time: 3:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Meeting Format: Virtual Meeting. 

Contact Person: Rebecca Steiner Garcia, 

Ph.D., Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

Neuroscience Center, 6001 Executive Blvd., 

Bethesda, MD 20892–9608, 301–443–4525, 

email: steinerr@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.242, Mental Health Research 

Grants, National Institutes of Health, HHS) 

Dated: December 20, 2024. 

Bruce A. George, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–30956 Filed 12–27–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary & 

Integrative Health; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Complementary and Integrative Health 

Special Emphasis Panel; Feasibility Trials of 

the NIH Music-based Interventions Toolkit 

for Brain Disorders of Aging (R34 Clinical 

Trial Required). 

Date: February 14, 2025. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Center for 

Complementary and Integrative Democracy 

II, 6707 Democracy Blvd., Bethesda, MD 

20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Baila S. Hall, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, Division of Extramural Activities, 

NCCIH/NIH, 6707 Democracy Blvd., Suite 

401, Bethesda, MD 20892, (301) 443–9285, 

baila.hall@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.213, Research and Training 

in Complementary and Alternative Medicine, 

National Institutes of Health, HHS) 

Dated: December 20, 2024. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2024–31209 Filed 12–27–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel; Review of Support for Research 

Excellence (SuRE) Award and Support for 

Research Excellence—First Independent 

Research (SuRE-First) Award (R16). 

Date: March 27, 2025. 

Time: 9:30 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

National Institute of General Medical 

Sciences, Natcher Building, 45 Center Drive, 

Bethesda, Maryland 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Kimberly Hammer, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institute of General Medical 

Sciences, National Institutes of Health, 45 

Center Drive, MSC 6200, Bethesda, Maryland 

20892, 301–594–2849, kimberly.hammer@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 

Dated: December 20, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–31147 Filed 12–27–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Final Revised Human 

Immunodeficiency Virus (HIV) Organ 

Policy Equity Act Safeguards and 

Research Criteria for Transplantation 

of Organs From Donors With HIV 

AGENCY: National Institutes of Health, 

Department of Health and Human 

Services. 

ACTION: Final notice. 

SUMMARY: Kidney and liver transplants 

from donors with HIV no longer require 

institutional review board (IRB)- 

approved research protocols or 

compliance with HHS research criteria 

per a November 27, 2024, final rule. 

Through this notice, the U.S. 

Department of Health and Human 

Services (HHS) announces the 

publication of this accompanying Final 

Revised Safeguards and Research 

Criteria for Transplantation of Organs 

from Donors with HIV to apply to nonkidney and non-liver organs from 

donors with HIV for transplantation in 

recipients with HIV. Under the HOPE 

Act, these transplants must still occur 

under an IRB-approved research 

protocol that is compliant with federal 

regulations governing human subjects’ 

research. The goal of this research is to 

increase knowledge about the safety, 

efficacy, and effectiveness of transplants 


ddrumheller on DSK120RN23PROD with NOTICES1